Experience after 100 patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 17

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

620

HTML

2892

Figures (1-1)

208

Tables (1-7)

217

Sum=3937

May 7, 2012 (publication date) through Aug 31, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. May 7, 2012; 18(17): 2061-2066
Published online May 7, 2012. doi: 10.3748/wjg.v18.i17.2061

Table 2 Clinical characteristics

Patients	n = 100
Age (yr)	54 (17-76)
American Society of Anesthesiologists [n (%)]
1	7 (7)
2	52 (52)
3	41 (41)
BMI (cm/kg²)	24 (17-41)
Time to PC from primary diagnosis (d)	365 (103-1009)

Data are presented as mean (min-max) or n (%). PC: Peritoneal carcinomatosis; BMI: Body mass index.

Citation: Königsrainer I, Zieker D, Glatzle J, Lauk O, Klimek J, Symons S, Brücher B, Beckert S, Königsrainer A. Experience after 100 patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. World J Gastroenterol 2012; 18(17): 2061-2066
URL: https://www.wjgnet.com/1007-9327/full/v18/i17/2061.htm
DOI: https://dx.doi.org/10.3748/wjg.v18.i17.2061